Nextgen Biotech

Call us:

Abiraterone Acetate Tablets for Wholesale (Prostiga 250mg)

Prostiga contains Abiraterone Acetate, an oral androgen biosynthesis inhibitor used to treat advanced prostate cancer. It works by suppressing androgen production, which fuels prostate tumor growth, making it an essential component in metastatic and castration-resistant cases.

Choose Quantity:

-
+
Share
General Information:
Generic Name: Abiraterone Acetate
Brand Name: Prostiga
Packing: 120 tablets
Strength: 250mg per tablet
Manufacturer: Smithways Health Care Pvt. Ltd.
Form: Oral tablet
Category: Anti-androgen, Androgen biosynthesis inhibitor, Antineoplastic agent (Hormonal therapy)
Product Introduction:
Prostiga 250mg is a potent anti-cancer hormonal therapy used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). It is typically administered in combination with prednisone to counteract mineralocorticoid excess caused by CYP17 inhibition.

Uses (Indications):
Prostiga (Abiraterone Acetate) is prescribed for:
  1. Metastatic castration-resistant prostate cancer (mCRPC)
  2. Metastatic castration-sensitive prostate cancer (mCSPC)
  3. Patients progressing after failure of docetaxel chemotherapy
  4. Hormone-sensitive prostate cancer with high tumor burden
  5. Used with prednisone to reduce side effects of mineralocorticoid excess
  6. Off-label: In combination regimens in clinical trials or early-stage high-risk prostate cancers

Storage Instructions:
  1. Store at room temperature between 20–25°C
  2. Protect from moisture, light, and heat
  3. Keep the medication in its original packaging
  4. Do not refrigerate or freeze
  5. Keep out of reach of children

How It Works (Mechanism of Action):
Abiraterone Acetate is a selective and irreversible inhibitor of the enzyme CYP17A1 (17α-hydroxylase/C17,20-lyase), which is crucial in androgen biosynthesis in the testes, adrenal glands, and prostate tumor tissue.
By inhibiting this enzyme, Abiraterone:
  1. Reduces the synthesis of testosterone and other androgens
  2. Starves prostate cancer cells of androgens, slowing or stopping their growth
  3. Has a more profound anti-androgen effect than first-generation agents (e.g., bicalutamide)
Because the drug also reduces cortisol production, prednisone is co-administered to prevent adrenal insufficiency and control mineralocorticoid-related side effects (like hypertension, hypokalemia, and fluid retention).

Side Effects:
Common Side Effects:
  1. Fatigue
  2. Joint swelling or discomfort (arthralgia)
  3. Hypertension (high blood pressure)
  4. Fluid retention / edema
  5. Hot flushes
Severe or Less Common Side Effects:
  1. Hypokalemia – low potassium levels requiring monitoring
  2. Liver enzyme elevation (hepatotoxicity)
  3. Adrenal insufficiency if not taken with prednisone
  4. Cardiac arrhythmias
  5. Urinary tract infections
  6. Bone fractures – due to androgen deprivation
  7. Rare: Sepsis, myopathy, increased fracture risk

Dosage (Typical Recommended Dose):
  1. Standard adult dose: 1,000 mg (i.e., four 250mg tablets) once daily
  2. To be taken on an empty stomach – at least 1 hour before or 2 hours after food
  3. Prednisone 5mg twice daily is co-administered
  4. Dose adjustments may be required in cases of hepatic impairment

Method of Administration:
  1. Administer orally with water, whole—do not crush or chew
  2. Take in the morning, at the same time daily
  3. Must be taken on an empty stomach to avoid increased absorption and toxicity
  4. Ensure concurrent prednisone therapy to prevent side effects

Precautions:
  1. Monitor for liver function abnormalities (AST, ALT, bilirubin)
  2. Monitor blood pressure, serum potassium, and fluid retention
  3. Use with extreme caution in patients with heart failure or history of arrhythmias
  4. Not indicated for use in women or pediatric patients
  5. Men should use effective contraception during and for 3 months after therapy
  6. Risk of bone loss—consider bone-modifying agents in long-term therapy

Drug Interactions:
  1. CYP3A4 inducers (e.g., rifampin) – may reduce Abiraterone effectiveness
  2. CYP2D6 substrates (e.g., metoprolol, desipramine) – increased levels possible
  3. CYP2C8 inhibitors – can increase drug concentration and toxicity
  4. Spironolactone – avoid due to its androgenic activity
  5. Co-administration with glucocorticoids (prednisone) is mandatory

Allergies (Warnings for Allergic Reactions):
  1. Rare allergic reactions such as rash, itching, or hives
  2. Discontinue immediately in case of angioedema, breathing difficulties, or anaphylaxis
  3. Not recommended in patients with known hypersensitivity to Abiraterone or excipients

Overdose Information:
  1. Symptoms may include fluid retention, hypokalemia, hypertension, or cardiac effects
  2. No specific antidote – provide supportive treatment
  3. Monitor vital signs, liver function, electrolytes, and perform ECG
  4. Seek emergency medical attention immediately in case of overdose

Missed Dose Instructions:
  1. If a dose is missed, take it as soon as remembered on the same day
  2. If missed entirely for a day, do not double dose the next day
  3. Continue regular dosing from the next scheduled dose
  4. Ensure prednisone is also taken as prescribed

Additional Notes:
  1. Abiraterone is a cornerstone treatment for late-stage prostate cancer
  2. Requires long-term hormone suppression and monitoring
  3. Regular PSA tests, imaging, and liver panels are needed during therapy
  4. Combining with GnRH agonists/antagonists may be necessary unless surgically castrated
  5. Alcohol and high-fat meals should be avoided to prevent adverse absorption changes
  6. Patients should carry steroid medication info (prednisone) at all times

In The Same Category

Cart